Compartmental Differences in NK Cell Responsiveness to IL-12 During Lymphocytic Choriomeningitis Virus Infection
Open Access
- 15 January 2000
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 164 (2) , 994-1001
- https://doi.org/10.4049/jimmunol.164.2.994
Abstract
Some, but not all, viral infections induce endogenous IL-12 to drive NK cell IFN-γ production and downstream antiviral defenses during innate immune responses. Even though lymphocytic choriomeningitis virus (LCMV) can be sensitive to IFN-γ-mediated antiviral effects, infections with this agent do not elicit IL-12 or early IFN-γ in immunocompetent hosts. Studies presented here demonstrate that LCMV infections of mice not only fail to induce IL-12, but also modify responsiveness to exogenous IL-12 for IFN-γ production. IFN-γ responses induced by IL-12 administration were greatly diminished in splenic populations, but significantly increased in serum and hepatic leukocytes, during the early course of LCMV infections. The IFN-γ production was NK cell dependent, and the compartmental dichotomy between spleen and liver was also demonstrated in response to in vitro IL-12 stimulation. Although infections did increase proportions and numbers of liver NK cells, changes in responsiveness for IFN-γ expression could not be explained by cell redistribution. Corroborating changes in proportions of NK cells induced to express intracellular IFN-γ protein within the compartments were observed. The reduction in ability of splenic populations to produce IL-12-induced IFN-γ after infection by LCMV was associated with decreased efficacy of administered IL-12 for promoting IFN-γ-dependent antiviral effects in the spleen. Concomitantly, the maintenance of hepatic population IFN-γ production was associated with preserved efficacy of administered IL-12 to elicit IFN-γ-dependent antiviral effects in the liver. Taken together, these results demonstrate modifications of compartmental responses to IL-12 by viral infections and the consequences of these changes for efficacy of cytokine therapy.Keywords
This publication has 31 references indexed in Scilit:
- NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate CytokinesAnnual Review of Immunology, 1999
- Delayed Administration of Interleukin-12 Is Efficacious in Promoting Recovery from Lethal Viral EncephalitisViral Immunology, 1999
- Early Murine Cytomegalovirus (MCMV) Infection Induces Liver Natural Killer (NK) Cell Inflammation and Protection Through Macrophage Inflammatory Protein 1α (MIP-1α)–dependent PathwaysThe Journal of Experimental Medicine, 1998
- Biological properties of interleukin‐12 and its therapeutic use in persistent hepatitis B virus and hepatitis C virus infectionJournal of Viral Hepatitis, 1997
- Activation and function of natural killer cell responses during viral infectionsCurrent Opinion in Immunology, 1997
- Tumor necrosis factor-α and interferon-γ inhibit synergistically viral replication in hepatitis B virus-replicating cellsJournal of Medical Virology, 1995
- Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.The Journal of Experimental Medicine, 1995
- Interleukin-12: A Proinflammatory Cytokine with Immunoregulatory Functions that Bridge Innate Resistance and Antigen-Specific Adaptive ImmunityAnnual Review of Immunology, 1995
- Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids.The Journal of Experimental Medicine, 1995
- Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ GenesScience, 1993